Importance of CSF-based Aβ clearance with age in humans increases with declining efficacy of blood-brain barrier/proteolytic pathways is a research paper published in Communications Biology (2022). On theSindex it has a DataRank of 0.609. It has been cited 57 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.609
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
Grant: DK 056341
U.S. Department of Health & Human Services | NIH | National Institute on Aging
Grant: K76 AG054863
U.S. Department of Health & Human Services | NIH | National Institute on Aging
Grant: R01AG054567
U.S. Department of Health & Human Services | NIH | National Institute on Aging
Grant: P01AG003991
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke
Grant: R01NS065667
NIA NIH HHS
Grant: P30 AG066509
NIDDK NIH HHS
Grant: P30 DK056341
National Institutes of Health
Grant: 5P01AG003991-38
Healthy Aging and Senile Dementia
National Institutes of Health
Grant: 5R01AG054567-04
Quantification of Neuroinflammation inAlzheimer's Disease Using Diffusion BasisSpectrum Imaging
National Institutes of Health
Grant: 2R01NS065667-05
CNS and Plasma Amyloid--Beta Kinetics in Alzheimer's Disease
National Institutes of Health
Grant: 2P30DK056341-11
Biomolecular Analysis Core
National Institutes of Health
Grant: 5K76AG054863-05
Sleep Quality and Human Amlyoid-Beta Kinetics
U.S. Department of Health & Human Services | NIH | National Institute on Aging
FWCI
4.55
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of A multicenter, randomized, double-blind, placebo-controlled ascending dose study to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamic (PD) effects of Posiphen in subjects with early Alzheimer’s Disease
Additional file 1 of A multicenter, randomized, double-blind, placebo-controlled ascending dose study to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamic (PD) effects of Posiphen in subjects with early Alzheimer’s Disease